I am pretty frustrated with the quality and presentation of

New Post Public Reply Private Reply Replies (6) Message Board
Buildit
431
I am pretty frustrated with the quality and presentation of some of the info we got over the past couple of days. Here are a few items that I'm a little perturbed about, and maybe someone can clear some of this up for me (at which point I'll be happy to apologize for my lack of understanding).


1) No one commented on my previous post, so I'll ask w better document references.

Does no one find it strange and confusing how history was revised between the Feb 18 S-1 and the S-1A on Monday?

Regarding the Oasis financing:

Original, page 9:

On November 25, 2019, we entered into a purchase agreement with Oasis, which we refer to in this prospectus as the “Oasis Purchase Agreement”, pursuant to which Oasis has agreed to purchase from us up to $40,000,000 of our common stock at 92% of the market price for the period of five (5) consecutive trading days immediately subject to a put notice on such date on which the purchase price is calculated in accordance with the terms and conditions of thegreement(subject to certain limitations) from time to time over a 36-month period. We also issued to Oasis 1,228,501 shares under the Oasis Purchase Agreement upon execution thereof. Also on December 6, 2019, we entered into a registration rights agreement, or the “Oasis Registration Rights Agreement”, with Oasis, pursuant to which we have filed with the SEC the registration statement that includes this prospectus to register for resale under the Securities Act of 1933, as amended, or the Securities Act, 15,542,133 of the shares that have been or may be issued to Oasis under the Oasis Purchase Agreement.


Amended, page 6:

On November 25, 2019, we entered into a purchase agreement with Oasis, which we refer to in this prospectus as the “Oasis Purchase Agreement”, pursuant to which Oasis has agreed to purchase from us up to $40,000,000 of our common stock at 92% of the market price for the period of five (5) consecutive trading days immediately subject to a put notice on such date on which the purchase price is calculated in accordance with the terms and conditions of thegreement(subject to certain limitations) from time to time over a 36-month period. We also issued to Oasis 1,719,901 shares under the Oasis Purchase Agreement upon execution thereof. Also on December 6, 2019, we entered into a registration rights agreement, or the “Oasis Registration Rights Agreement”, with Oasis, pursuant to which we have filed with the SEC the registration statement that includes this prospectus to register for resale under the Securities Act of 1933, as amended, or the Securities Act, 21,758,986 of the shares that have been or may be issued to Oasis under the Oasis Purchase Agreement.
________________________________________

It is NOT true that both of these scenarios happened, with different quantities of stock being issued to open the deal with Oasis and different quantities of stock being registered with the SEC on the same dates.

Shouldn't this be stated as a change to the original plan, with a restatement of the filing to the SEC with the new quantity?

Or separately, were the shares not actually issued in November, and none of this is approved, so it hasn't actually happened yet?

One way or another, history cannot be simply altered, despite what some people in this country seem to think.


2) The same idea is true for the Discover deal:

Original, page 7:

On December 9, 2019, we entered into a purchase agreement with Discover Growth Fund LLC (“Discover”), pursuant to which we issued and sold to Discover an original issue discount convertible note (the “Discover Note”) in the principal amount of $2,200,000, for a purchase price of $2,000,000. We also issued to Discover 100,000 shares of common stock.

This prospectus includes the resale of 11,100,000 shares of common stock issued or issuable to Discover, including 100,000 shares upon execution of the purchase agreement with Discover, and 11,00,000 shares of common stock issuable upon conversion of the Discover Note.


Amended, page 10:

On December 9, 2019, we entered into a purchase agreement with Discover Growth Fund LLC (“Discover”), pursuant to which we issued and sold to Discover an original issue discount convertible note (the “Discover Note”) in the principal amount of $2,200,000, for a purchase price of $2,000,000. We also issued to Discover 140,000 shares of common stock.

This prospectus includes the resale of 15,540,000 shares of common stock issued or issuable to Discover, including 140,000 shares upon execution of the purchase agreement with Discover, and 15,400,000 shares of common stock issuable upon conversion of the Discover Note.

_______________________________________

Maybe that is an adjustment due to the lawsuit, and this is a recalculation to resolve the fact that the deal was set up in an incalculable way?

If so, it again seems strange to me that it is simply restated as if that is how it originally happened, as opposed to saying "here is the amended deal we entered to settle our disagreement over the terms"... because it isn't true that GNBT issued both 100k and 140k shares to Discover on 12/9/19, and the millions of shares stated to be issued are not what was originally agreed upon... so explain the new deal, don't restate it as if that's how it was agreed upon on the original date.


3) (I suppose this is the one Pokey was really alluding to earlier, but I haven't heard back from him.)

I can't find any difference between the S-1 for the preferred stock offering and the S-1A that was issued on that same offering. Not only that, but the S-1A was filed 2 hours before the S-1 was actually filed. Could that be the entirety of it, that they mistakenly filed it as an S-1A and then had to file it as an original S-1? Good grief.


4) How does a 10MM discrepancy in outstanding shares get publicized? If the OS is ~80MM shares, then let's be certain we don't put out an S-1 that says it's 90MM shares!


5) Holy crap, what is THIS (appears to be new - Page 35 of the Pref Shares S-1):

We are subject to a court order that prohibits us from issuing shares.

In connection with an action brought against us by Iliad, we are subject to a court order that prohibits us from issuing any shares of stock without receiving court approval (see “Legal Proceedings”). If the order continues to be in place and we obtain approval from the court to issue the Series A Preferred Stock, we may still be unable to obtain the court’s consent for additional issuances of our shares of stock. This may have a material adverse effect on our ability to raise capital and on our liquidity and capital resources.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 3

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 6

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 1

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 1

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 3

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 2

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 1

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 3

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading

Top 5 Most Recently Viewed Articles

Key Investor Conferences to Watch This Quarter for Growth

Updated Category News Views 256

Introduction to Q1 Investor Conferences This year has begun with a dynamic mix of geopolitical events that have positively impacted domestic energy-sector stocks. As we venture into 2026, the buzz around technological advancements, especially in artificial intelligence, is palpable. Investors are keenly awaiting insights and trends that will be presented at various...

Continue Reading
Triton Digital Unveils U.S. Podcast Rankings for November 2024

Updated Category News Views 191

Overview of the November 2024 Podcast Metrics Triton Digital, a leading provider of technology and services in the digital audio and podcasting sector, has unveiled its reporting period for November 2024, covering from November 4 to December 1. This release comes from Triton’s Podcast Metrics measurement service, which offers critical insights into podcast performances...

Continue Reading
Treasury Bonds Auction Insights: RIKB 26 1015 & RIKB 38 0215

Updated Category News Views 150

Overview of Treasury Bonds Auction Results In a recent auction, two significant treasury bonds were featured: RIKB 26 1015 and RIKB 38 0215. The auction process is a crucial activity in the finance world, presenting opportunities for investors to acquire bonds issued by the government. Each bond serves different funding needs, making it essential to assess their...

Continue Reading
DeepQure's New Clinical Leadership: A Vision for Hypertension Care

Updated Category News Views 162

DeepQure Welcomes New Global Vice President DeepQure, a trailblazer in innovative treatments for hypertension, has made a significant step forward with the recent appointment of Jason G. Jones as the Global Vice President of Clinical & Regulatory Affairs. This strategic move is expected to amplify DeepQure's ambitions as it seeks to redefine hypertension management with...

Continue Reading
Wave Life Sciences Unveils Promising Data for WVE-007 Obesity Therapy

Updated Category News Views 236

Wave Life Sciences Presents Preclinical Findings at ObesityWeek 2025 Wave Life Sciences Ltd. (NASDAQ: WVE), a pioneering biotechnology firm, is excited to share breakthrough preclinical data on WVE-007, an innovative siRNA therapeutic targeting obesity. This research will be spotlighted in a poster presentation at ObesityWeek 2025, which features insights into how WVE-007...

Continue Reading